✦ LIBER ✦

B-Cell Targeted Therapy With Rituximab for Thyroid Eye Disease: Closer to the Clinic

✍ Scribed by Shen, Sunny; Chan, Anita; Sfikakis, Petros P.; Hsiu Ling, Andrea Low; Detorakis, Efstathios T.; Boboridis, Kostas G.; Mavrikakis, Ioannis

Book ID: 123050090
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 392 KB
Volume: 58
Category: Article
ISSN: 0039-6257
DOI: 10.1016/j.survophthal.2012.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

B-cell depletion with rituximab—a target

B-cell depletion with rituximab—a targeted therapy for Graves’ disease and autoimmune thyroiditis

✍ Hans Carl Hasselbalch 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Targeted biological therapies for Graves

Targeted biological therapies for Graves’ disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab

✍ Laszlo Hegedüs; Terry J. Smith; Raymond S. Douglas; Claus H. Nielsen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

The effect of adding rituximab to CHOP-b

The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma: a propensity score matching analysis

✍ Hisakazu Nishimori; Keitaro Matsuo; Yoshinobu Maeda; Yuichiro Nawa; Kazutaka Sun 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 201 KB

Applying standard therapies to new targe

Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease

✍ Isabelle Vonder Muhll; Peter Liu; Gary Webb 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 270 KB

A phase I/II trial to evaluate the safet

A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP for the treatment of patients with relapsed or refractory diffuse large cell B-Cell lymphoma – the STORM trial

✍ Mathias Witzens-Harig, Marie Luise Memmer, Martin Dreyling, Georg Hess 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 171 KB

[American Thoracic Society American Thor

[American Thoracic Society American Thoracic Society 2010 International Conference, May 14-19, 2010 • New Orleans - ()] B16. PULMONARY ARTERIAL HYPERTENSION: FROM ASSESSING RISK TO THERAPEUTIC RESULTS - Evaluation Of Sildenafil Therapy For Patients With Sickle Cell Disease And Increased Tricuspid Regurgitant Velocity: Preliminary Results Of The Walk-PHaSST Trial

✍ Machado, Roberto F.; Barst, Robyn J.; Yovetich, Nancy A.; Hassell, Kathryn L.; G 📂 Article 📅 2010 🏛 American Thoracic Society ⚖ 21 KB